Form 3 - Initial statement of beneficial ownership of securities

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 3 - Initial statement of beneficial ownership of securities

C4 Therapeutics (NASDAQ:CCCC)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more C4 Therapeutics Charts.

C4 Therapeutics (NASDAQ:CCCC)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more C4 Therapeutics Charts.

C4 Therapeutics Inc News

Form 8-K - Current report
Tuesday 14 January 2025 (2 days ago) • Edgar (US Regulatory)

C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology
Tuesday 14 January 2025 (2 days ago) • GlobeNewswire Inc.

C4 Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Wednesday 8 January 2025 (1 week ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 9 December 2024 (1 month ago) • Edgar (US Regulatory)

C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader
Sunday 8 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 20 November 2024 (2 months ago) • Edgar (US Regulatory)

C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
Wednesday 20 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Monday 18 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

More C4 Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions